Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Atossa Therapeutics Inc has a consensus price target of $6.25 based on the ratings of 3 analysts. The high is $6.5 issued by Ascendiant Capital on September 11, 2024. The low is $6 issued by HC Wainwright & Co. on November 5, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Ascendiant Capital on November 5, 2024, October 31, 2024, and September 11, 2024, respectively. With an average price target of $6.17 between HC Wainwright & Co., HC Wainwright & Co., and Ascendiant Capital, there's an implied 308.47% upside for Atossa Therapeutics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Atossa Therapeutics (NASDAQ:ATOS) was reported by HC Wainwright & Co. on November 5, 2024. The analyst firm set a price target for $6.00 expecting ATOS to rise to within 12 months (a possible 297.43% upside). 12 analyst firms have reported ratings in the last year.
The latest analyst rating for Atossa Therapeutics (NASDAQ:ATOS) was provided by HC Wainwright & Co., and Atossa Therapeutics reiterated their buy rating.
There is no last upgrade for Atossa Therapeutics
There is no last downgrade for Atossa Therapeutics.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Atossa Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Atossa Therapeutics was filed on November 5, 2024 so you should expect the next rating to be made available sometime around November 5, 2025.
While ratings are subjective and will change, the latest Atossa Therapeutics (ATOS) rating was a reiterated with a price target of $6.00 to $6.00. The current price Atossa Therapeutics (ATOS) is trading at is $1.51, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.